Peer Review History
| Original SubmissionMay 17, 2021 |
|---|
|
PONE-D-21-15652Trends, Barriers and Enablers to Measles Immunization Coverage in Saskatchewan, Canada: a Mixed Methods StudyPLOS ONE Dear Dr. Ilesanmi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ACADEMIC EDITOR: The academic editor served as the second reviewer nd agreed major revision need to be addressed in order for the manuscript to be considered for publication. ============================== Please submit your revised manuscript by Jan 18 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Joseph Telfair, DrPH, MSW, MPH Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. Additional Editor Comments (if provided): The academic editor served as the second reviewer nd agreed major revision need to be addressed in order for the manuscript to be considered for publication. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: General comment The topic of the article proposed by the researchers is interesting, it is a contribution to the analysis of measles vaccination trends, from a mixed approach. The data is limited to the province of Sasketchewan, but could be understood given the qualitative approach the authors add to the study. However, I am concerned about the lack of concurrency in the temporality of the quantitative and qualitative approaches. I can understand that the quantitative data for this study only includes up to the year 2013, while the qualitative analysis would correspond to a more current information collection (the authors do not report on this). If so, this temporal gap would mean that the social, historical and cultural context in which the analysis is carried out is not the same. Ideally, I would suggest to the authors to extend the trend analysis to a more current date, closer to the period in which the data from the qualitative approach were collected. Here are some questions and suggestions for authors. Summary Line 32. It is not clear in what time or periods of time the interviews with the key informants were taken. Introduction Lines 75-78. Specify in the province of Saskatchewan, what is the regular schedule of measles vaccination in the first and second doses. Materials and methods Line 145. Specify if the vaccination coverage was obtained: annually? For the entire province or for each of the regions? Justify why a data analysis is performed only up to 2013, why more recent data is not included. Lines 153-156. Describe in what time period the key informant interviews were conducted. Describe whether there was triangulation of qualitative information and how it was done. How do the authors justify a quantitative analysis of data from 2010-2013, while the qualitative analysis corresponds to a current period of time? That is, although there is a mixed approach to the research, the authors have worked with a quantitative and qualitative approach at two different, non-concurrent moments. Statistical analysis An analysis of differences by socioeconomic quintiles is carried out in the results. It is necessary to describe in the Statistical analysis section where this information was obtained and how it was included in the analysis. I consider that, when evaluating the disparity in measles coverage by socioeconomic status, the authors could delve deeper into the results, there are some inequality analyzes that could perhaps be applied in the present study, as well as exploring differences by urban, rural, between migrants, between indigenous and non-indigenous populations Results Lines 223-224. Are you referring to first or second dose coverage for measles, or full schedule coverage? Line 240-251. Specify what S-EDQ1 means. It is the first time that the abbreviation has been used but I cannot find what it corresponds to in the text. In addition to mentioning it in the Abbreviations section, it should also be included in the main text. Again, I would suggest including additional analysis on inequality in vaccination coverage, for example, differences by urban and rural sector, between migrants, between indigenous and non-indigenous populations. Particularly, in the qualitative part, the differences between the urban and rural sectors are mentioned; It would be interesting to see if these differences are evident in the quantitative part. Discussion Line 430. What does HIT mean? Line 433. To what period of time do these contextual adaptations refer (between 2002-2013? Or later). Since when did promoters of community programs begin to be introduced? Could it be observed if the presence of community program promoters really had an effect on vaccination coverage? Line 448. What period of time do you refer to? Line 454 and following. I suggest, for the reader's clarity, to make a summary table of the changes over time in health strategies and policies related to vaccination, which are mentioned both in the results and in the discussion. Figures. Figure 2. Include a note at the bottom of the figure that explains the graph and legends. Explain what S-EDQ is. Figure 5. Include a footnote to the figure that explains the graph and captions. Explain what is DEP 1, 2 etc. Figure 6. Include title, explain the main elements of the figure in a footnote. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-21-15652R1Trends, Barriers and Enablers to Measles Immunization Coverage in Saskatchewan, Canada: a Mixed Methods StudyPLOS ONE Dear Dr. Ilesanmi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 06 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Fernanda Penido Matozinhos, Ph.D Academic Editor PLOS ONE Additional Editor Comments (if provided): Dear authors, Thank you for submitting your manuscript to PLOS ONE and making substantial changes in the manuscript. After careful consideration, we feel that the goal of this study is relevant and it has technical rigor but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process – specially in the Results’ section. Kind regards, [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I consider that the authors made the necessary changes and/or explanations required to guarantee the quality of the scientific article and corroborate the evidence presented. Reviewer #2: Thanks to the authors for making substantial changes and revising the manuscript titled 'Trends, Barriers and Enablers to Measles Immunisation 1 Coverage in Saskatchewan Canada: a Mixed Methods Study'. This version looks much better. Some more edits and revisions are suggested below: Please read and re-read the Abstract and for the full manuscript to fix the typos, and sentence construction errors. The reviewed pdf version with comments is attached herewith that'd aide authors on the specific corrections to be made. Abstract: Please explain what constitutes 'social' and 'institutional' factors for immunization in the Methods section, and thereafter add this sentence Keywords: Please delete repetitions - e.g. 'coverage' Introduction: Please consider making this section more concise. Also in describing the measles vaccination scenario, introduce the global scenario, thereafter Canada, and lastly the study location. Currently, it is all over the place. Methods and Results - Please have separate sections and subheadings for Quantitative and Qualitative when describing Data Source, and Data Analysis. Similarly in Results, report the Quantitative results first followed by the Qualitative Results. Results: This section needs the maximum revision. Please make the results section concise. Report only the findings here. Was any coding of the interviews undertaken to categorize the results under these 4 subheads? Access issues, fear issues, Anti vax issues, and systematic issues? If so, that needs to be elaborated, OR was this categorization adapted from any particular study or theoretical framework? If so that/those studies needs to be quoted. More quotes are required to elaborate each section. Currently, the findings are mentions, without supporting quotes. Discussion: Enhancement is needed in this section with addition of more citations FOR COMMUNITY ENGAGEMENT Dutta, T., Agley, J., Meyerson, B. E., Barnes, P. A., Sherwood-Laughlin, C., & Nicholson-Crotty, J. (2021). Perceived enablers and barriers of community engagement for vaccination in India: Using socioecological analysis. Plos one, 16(6), e0253318. Dutta, T., Meyerson, B. E., Agley, J., Barnes, P. A., Sherwood-Laughlin, C., & Nicholson-Crotty, J. (2020). A qualitative analysis of vaccine decision makers’ conceptualization and fostering of ‘community engagement’in India. International journal for equity in health, 19(1), 1-14. FOR CULTURE RESPONSIVE VACCINATION MESSAGING Dutta, T., Agley, J., Lin, H. C., & Xiao, Y. (2021, May). Gender-responsive language in the National Policy Guidelines for Immunization in Kenya and changes in prevalence of tetanus vaccination among women, 2008–09 to 2014: A mixed methods study. In Women's Studies International Forum (Vol. 86, p. 102476). Pergamon. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Tapati Dutta ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 2 |
|
Trends, Barriers and Enablers to Measles Immunization Coverage in Saskatchewan, Canada: a Mixed Methods Study PONE-D-21-15652R2 Dear authors, the manuscript explores a very important topic and it has technical rigor. Thank you for submitting your manuscript to PLOS ONE and making substantial changes in order to improve the manuscript. We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Fernanda Penido Matozinhos, Ph.D Academic Editor PLOS ONE Additional Editor Comments (optional): Dear authors, the manuscript explores a very important topic and it has technical rigor. Thank you for submitting your manuscript to PLOS ONE and making substantial changes in order to improve the manuscript. We recommend its publication. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-21-15652R2 Trends, Barriers and Enablers to Measles Immunisation Coverage in Saskatchewan, Canada: a Mixed Methods Study Dear Dr. Ilesanmi: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Fernanda Penido Matozinhos Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .